Overview

Randomized Open Investigation Determining Steroid Dose

Status:
Recruiting
Trial end date:
2022-04-19
Target enrollment:
Participant gender:
Summary
Dexamethasone has been approved for the treatment of severe COVID-19, but higher doses of steroids may be more effective. The purpose of this research study is to compare the current standard dose of dexamethasone 6 mg to a higher, weight-based dosing (0.2 mg/kg with maximum dose of 20 mg) to determine if it would be more effective against COVID-19 pneumonia.
Phase:
Phase 4
Details
Lead Sponsor:
Northwell Health
Treatments:
BB 1101
Dexamethasone
Dexamethasone acetate